Biosimilars Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1290 | Report Format : | Status : Upcoming |

Abstract

Global Biosimilars Market: Overview

Biosimilar is a biopharmaceutical product which is similar to the previous or the original existing product that is manufactured by a company. The biosimilar also has alternative names such as subsequent entry biologic or follow-on biologic. When the patent of the original product expires biosimilars can be manufactured which are approved officially. When the patent expires of an approved recombinant drug any other biotech company can generate and market these biologics, thus the name biosimilars.

Global Biosimilars Market: Segmentation

The global biosimilars market is segmented into its product, manufacturing type and application. Based on the product, the market is segregated into recombinant non-glycosylated proteins, recombinant peptides, and recombinant glycosylated proteins. Further, the recombinant non-glycosylated proteins are sub-segmented into granulocyte colony-stimulating factor, interferons, insulin, and recombinant human growth hormones. The recombinant glycosylated proteins segment is sub-segmented into urofollitropin, erythropoietin, and monoclonal antibodies. the insulin and granulocyte colony-stimulating factor segment is sub-segmented into calcitonin and glucagon. On the basis of the manufacturing type, the market is categorized into contract manufacturing organizations and in-house manufacturing. On the basis of application, the market is divided into blood disorders, growth hormone deficiency, oncology, chronic & autoimmune diseases, infectious diseases, and others.

Global Biosimilars Market: Growth Factors

The major factor that contributed to the biosimilars market growth is the emergence of the biologic products that are off-patent. These drugs are very cost-effective thus making its demand to increase substantially. In the coming years, this demand for the biosimilars is going to increase. The increasing rate of the diseases across the globe has also helped in contributing towards the market growth. The manufacturers of the biologic drug have started to take initiatives in making innovative strategies in order to develop the biosimilars market. Even though the market is in a phase where it is flourishing there are some restraining factors that are affecting the market growth. The factors such as lengthy clinical trials which are required from the regulatory bodies for approval and the production of biosimilars require complex infrastructure are affecting the market growth.

Global Biosimilars Market: Regional Analysis

The biosimilars market is geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World. The region that is leading the biosimilars market is Europe and it accounts for the largest share in the global market. The factors that have attributed to this growth are Omni trope, bino crits, and lenograstim. Additionally, the strict regulatory framework and the increasing pipeline products estimate to contribute towards the growth of the European biosimilars market. There are opportunities increasing in the regions such as Asia Pacific region. As per the study, the Asia-Pacific region will have a progressive growth rate in the coming years. The stringent protocols in the US are hampering the biosimilars market in the North American region.

Global Biosimilars Market: Competitive Players

The key market players in the biosimilars market include Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Biocon Ltd., F. Hoffmann-La Roche Ltd., Samsung Bioepis, Sandoz International GmbH, Amgen Inc., Dr. Reddy’s Laboratories Ltd. and Celltrion, Inc.

Global Biosimilars Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Pharmaceutical Contract Packaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2061 | Report Format:

Global Pharmaceutical Contract Packaging Market: Overview Outsourcing of the packaging activities to the third party manufacturers is pharmaceutical contract packaging. The drug manufacturing companies are taking the services of other packaging parties for the packaging of the drugs thus saving ...Read More

Ocular Implants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2060 | Report Format:

Global Ocular Implants Market: Overview Ocular implants are used for the medical surgeries that deal with the replacement of the injured eye or to increase the sharpness of the vision. Different types of implants are available in the market which can be used for the treatment of various eye diso...Read More

Balanced Salt Solution For Cell Culture Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2057 | Report Format:

Global Balanced Salt Solution For Cell Culture Market: Overview A combination or mixture of the inorganic salts is called the balanced salt solution and it is generally used as a carbohydrate for the energy source. The balanced salt solutions are used for maintaining the mammalian cells for a sh...Read More

Incretin-Based Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2051 | Report Format:

Global Incretin-Based Drugs Market: Overview When the blood glucose levels decrease a group of metabolic hormones is stimulated which is known as incretins. Incretin-based drugs include glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors which are the new grou...Read More

Dunnage Air Bags Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2030 | Report Format:

Global Dunnage Air Bags Market: Overview The packaging industry worldwide has projected a fabulous growth in the recent years. This has positively impacted the shipping and logistic company as there has been a tremendous rise in the logistics and transportation services. All these shipping and l...Read More

Choose License Type:
Latest Published Reports

View All Published Reports